Klor-con M
Pricing Report NDC 66758-190-10

Latest NADAC: $0.41586 per EA · Effective Sep 18, 2019 · Est. package price $415.86 (1000 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Klor-con M (NDC 66758-190-10) is $0.41586 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Sep 18, 2019.

As a provided by Sandoz Inc., this medication is distributed in a 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.41586
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Sep 18, 2019
Billable Units
1000 EA
Estimated Package Price
$415.86
Data Status
As of Sep 02, 2020
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B-ANDA - Abbreviated New Drug Application
Package NDC
66758-190-10
Description
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $0.25547 (Effective: Aug 19, 2020)
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Dec 2014, the NADAC wholesale price for (NDC ) has moved within a range of $0.18205 to $0.48172 per EA. Over this 6 years and 9 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1821 - $0.4817
Market Volatility
164.61% Variance
Latest Trend
26.73%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 22, 2021 $0.25243 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Sep 22, 2021 $0.25243 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Aug 18, 2021 $0.19918 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Aug 18, 2021 $0.19918 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Aug 18, 2021 $0.19918 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Aug 18, 2021 $0.19918 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Aug 18, 2021 $0.19918 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Aug 18, 2021 $0.19918 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Apr 21, 2021 $0.18205 EAC/I - Chain or Independent PharmacyCode 1, 6B-ANDA - Abbreviated New Drug Application
Apr 21, 2021 $0.18205 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Apr 21, 2021 $0.18205 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application
Apr 21, 2021 $0.18205 EAC/I - Chain or Independent PharmacyCode 4, 6B-ANDA - Abbreviated New Drug Application

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026